SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Array Biopharma, Inc
An SI Board Since March 2005
Posts SubjectMarks Bans Symbol
321 29 0 ARRY
Emcee:  keokalani'nui Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
121Hadn't noticed, but Novartis recently cued up combo trial with <i>thirscaram(o)uche-10/28/2011
120Topline Results: A Randomized Phase 2 Study of Selumetinib in Patients with KRASsim1-9/30/2011
119Oncol Res. 2011;19(7):349-63. Single-agent inhibition of Chk1 is antiproliferascaram(o)uche-9/25/2011
118Blood. 2011 Sep 12. [Epub ahead of print] Cytokinetically quiescent (G0/G1) huscaram(o)uche-9/15/2011
117Cancer Biol Ther. 2011 Nov 1;12(9). [Epub ahead of print] Chk1 inhibition and Wscaram(o)uche-9/8/2011
116Good deal for ARRY. I posted my thoughts on the deal and on the quarterly resulmcbio-8/8/2011
115Business goes on: Array Announces New Oncology Agreement with Genentech Font sisjemmeri-8/8/2011
114FWIW - Conway bought another 25K shares today.mcbio-6/17/2011
113>> Sick of you, Conway! You haven't fed the pipe as many expected, andscaram(o)uche16/15/2011
112Array BioPharma Announces Restructuring Aligning Resources with Clinical Prograsim1-6/13/2011
111>> $$$$-potential obligations << Observations, even. :-)scaram(o)uche-6/13/2011
110No expert here. Just an avid biotech follower. ; ) Thanks for the props on thmcbio-6/13/2011
109Seems like the expert asking the question, and the follower answering, but.... scaram(o)uche-6/13/2011
108Conway had a recent insider buy (hadn't been any of those in awhile). Any cmcbio-6/12/2011
107I am so sick and tired of 10b5-1 gangs who maintain companies to pay (and pad) sscaram(o)uche-5/9/2011
10640 studies...... clinicaltrials.gov So I'm going to resist any future urgescaram(o)uche-12/8/2010
105Array BioPharma Achieves Clinical Milestone in Celgene Collaboration Press Relesim1-11/30/2010
104Array BioPharma Reports Financial Results for the First Quarter of Fiscal 2011 sim1-11/8/2010
103Invest New Drugs. 2010 Oct 27. [Epub ahead of print] Dermatologic side effects scaram(o)uche-10/28/2010
102Cancer Res. 2010 Oct 19. [Epub ahead of print] Basal and Treatment-Induced Actiscaram(o)uche-10/21/2010
101Mol Cancer Ther. 2010 Oct 5. [Epub ahead of print] Identification of Predictivescaram(o)uche-10/9/2010
100siliconinvestor.comDewDiligence_on_SI-10/6/2010
99Roche pays another $175M for ITMN-191, conference call (ITMN) in 20 minutes.scaram(o)uche-10/6/2010
98<i>nothing product relevant</i>..... PLoS One. 2010 Sep 23;5(9). piscaram(o)uche-10/6/2010
97Can Array BioPharma Attract Yet Another Partner? October 05, 2010 By Patrick Csim1-10/5/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News